Angiex
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
150 Cambridgepark Dr Fl 5, Cambridge, Ma...Phone Number
(617) 576-1753Website
www.angiex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Angiex
Angiex is focused on developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates (ND-ADCs) aimed at addressing the critical aspects of cancer lethality. Their innovative Nuclear Delivery Platform enables targeted delivery of chemotherapeutic agents to the nucleus of tumor cells, potentially revolutionizing treatments for solid tumors. The company's lead ND-ADC, AGX101, is set to enter clinical trials along with a pipeline of additional therapies currently in development. Angiex aims to provide safe and effective cancer therapies, aspiring to make cancer a non-lethal disease.Explore more
Angiex Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Angiex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Angiex has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Angiex has new funding data
Click to see if Angiex had a recent Job posting/layoffs
Earning: See what the market has to say on Angiex recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Angiex launches new products
Congratulate Masked Content for being promoted to Masked Content at Angiex
Check out if Angiex is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Angiex, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Angiex
Find 2 more new buyers
Compare Similar Companies to Angiex
Compare insights from companies similar to Angiex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Angiex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Angiex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Angiex.
Angiex financials insights
Gather financial insights about Angiex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$2.9M
2025
Private Equity
$11M
Angiex Tech Stack
A closer look at the technologies used by Angiex
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Partnership
Partnership, Research & Development, Logistics / Supply Chain, Medical Research
New Hire
Executive Move
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Angiex
Sign Up For FreeTo access detailed company insights
Angiex is focused on developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates (ND-ADCs) aimed at addressing the critical aspects of cancer lethality. Their innovative Nuclear Delivery Platform enables targeted delivery of chemotherapeutic agents to the nucleus of tumor cells, potentially revolutionizing treatments for solid tumors. The... Read More
